Chung, H. J., Choi, Y. E., Kim, E. S., Han, Y., Park, M., & Bae, I. H. (2015). miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2. Oncotarget.
Dyfyniad Arddull ChicagoChung, Hyun Joo, Young Eun Choi, Eun Sook Kim, Young-Hoon Han, Myung-Jin Park, and In Hwa Bae. "MiR-29b Attenuates Tumorigenicity and Stemness Maintenance in Human Glioblastoma Multiforme By Directly Targeting BCL2L2." Oncotarget 2015.
Dyfyniad MLAChung, Hyun Joo, et al. "MiR-29b Attenuates Tumorigenicity and Stemness Maintenance in Human Glioblastoma Multiforme By Directly Targeting BCL2L2." Oncotarget 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.